Skip to content
Advertisement

The Walgreens logo on the front of a store, July 14, 2021, in Cambridge, Mass. A huge opioid settlement dragged Walgreens to a $3.7 billion loss in its fiscal first quarter, but the drugstore chain still beat Wall Street forecasts. The company also reaffirmed its earnings forecast for the new year. Walgreens said Thursday, Jan. 5, 2023 that it recorded a $5.2-billion, after-tax charge in the quarter that ended November 30 for opioid-related litigation. (AP Photo/Charles Krupa, File)

The Walgreens logo on the front of a store, July 14, 2021, in Cambridge, Mass. A huge opioid settlement dragged Walgreens to a $3.7 billion loss in its fiscal first quarter, but the drugstore chain still beat Wall Street forecasts. The company also reaffirmed its earnings forecast for the new year. Walgreens said Thursday, Jan. 5, 2023 that it recorded a $5.2-billion, after-tax charge in the quarter that ended November 30 for opioid-related litigation. (AP Photo/Charles Krupa, File)

Featured Photo Galleries